caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1275614687

Mimi SohnMD

PRACTICEMUSCSee all providers at this practice →
NeurologyCharleston, SCI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 420004
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
188
Unique beneficiaries
—
Total services
65,668
Distinct HCPCS
2
Medicare payment
$354K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 198 Neurology providers in SC — top quintile (cohort median 821).
REFERRAL NETWORK

Where Mimi Sohn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MEDICAL UNIVERSITY HOSPITAL AUTHORITY75342
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MEDICAL UNIVERSITY HOSPITAL AUTHORITY29106
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
79.0
Quality
62.4
Cost
72.7
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.17%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,132
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
18
Brand share
79.2%
Top prescribed drugs
Rimegepant Sulfate312 claims
Ubrogepant189 claims
Galcanezumab-Gnlm86 claims
Erenumab-Aooe85 claims
Fremanezumab-Vfrm66 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$139
Payment records
3
By payment type
Food and Beverage$139